Compound Summary
CHELIDAMIC ACID
Compound Information
CHELIDAMIC ACID
Compound Name: | CHELIDAMIC ACID |
Compound CID: | 8743 |
Synonyms: | CHELIDAMIC ACID 4-Hydroxypyridine-2,6-dicarboxylic acid 138-60-3 4-oxo-1,4-dihydropyridine-2,6-dicarboxylic acid 499-51-4 More... |
Iupac Name: | 4-oxo-1H-pyridine-2,6-dicarboxylic acid |
InChI: | InChI=1S/C7H5NO5/c9-3-1-4(6(10)11)8-5(2-3)7(12)13/h1-2H,(H,8,9)(H,10,11)(H,12,13) |
InChIKey: | XTLJJHGQACAZMS-UHFFFAOYSA-N |
Canonical Smiles: | C1=C(NC(=CC1=O)C(=O)O)C(=O)O |
Isomeric Smiles: | C1=C(NC(=CC1=O)C(=O)O)C(=O)O |
Molecular Weight: | 183.12 |
Molecular Formula: | C7H5NO5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
CHELIDAMIC ACID
Molecular Weight: | 183.12 |
Molecular Formula: | C7H5NO5 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 13 |
Complexity: | 320 |
Synonyms
CHELIDAMIC ACID
| CHELIDAMIC ACID | CHELIDAMIC ACID |
|---|---|
CHELIDAMIC ACID |
4-Hydroxypyridine-2,6-dicarboxylic acid |
138-60-3 |
4-oxo-1,4-dihydropyridine-2,6-dicarboxylic acid |
499-51-4 |
4-oxo-1H-pyridine-2,6-dicarboxylic acid |
Chelidamic acid hydrate |
2,6-Pyridinedicarboxylic acid, 1,4-dihydro-4-oxo- |
4-HYDROXY-2,6-PYRIDINEDICARBOXYLIC ACID |
1,4-Dihydro-4-oxopyridine-2,6-dicarboxylic acid |
UNII-1A59BH8SXE |
1A59BH8SXE |
2,6-Pyridinedicarboxylic acid, 4-hydroxy- |
CHEMBL252909 |
4-Oxo-1,4-dihydro-2,6-pyridinedicarboxylic acid |
4-oxohydropyridine-2,6-dicarboxylic acid |
NSC 3983 |
EINECS 205-335-8 |
Lopac-C-8011 |
Chelidamic acid, AldrichCPR |
Lopac0_000298 |
MLS000042771 |
SCHEMBL742928 |
2, 1,4-dihydro-4-oxo- |
DTXSID00160451 |
NSC3983 |
HMS2439A21 |
HMS3260L18 |
AMY13329 |
NSC-3983 |
ZINC6523946 |
Tox21_500298 |
BBL028110 |
BDBM50229870 |
MFCD00066478 |
SBB069057 |
STK793046 |
STL259705 |
AKOS000279986 |
AKOS003233475 |
CCG-204393 |
CS-W017065 |
DS-1684 |
HY-W016349 |
LP00298 |
MCULE-2551574396 |
SDCCGSBI-0050286.P002 |
NCGC00015270-01 |
NCGC00015270-02 |
NCGC00015270-03 |
NCGC00015270-04 |
NCGC00015270-05 |
NCGC00093748-01 |
NCGC00093748-02 |
NCGC00260983-01 |
BP-12395 |
SMR000036248 |
AB0069409 |
AB0071625 |
DB-012857 |
DB-082252 |
C0821 |
EU-0100298 |
FT-0623584 |
FT-0712040 |
ST50308105 |
A18191 |
C 8011 |
1,4-dihydro-4-oxo-2,6-pyridinedicarboxylic acid |
138O603 |
A827903 |
AC-907/25014159 |
SR-01000075782 |
4-Oxo-1,4-dihydro-2,6-pyridinedicarboxylic acid # |
J-400830 |
J-515530 |
Q2667856 |
SR-01000075782-1 |
chelidamic acid (4-hydroxypyridine-2,6-dicarboxylic acid) |
2,6-Pyridinedicarboxylic acid, 1,4-dihydro-4-oxo- (8CI)(9CI) |
Experimental Data
CHELIDAMIC ACID
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 5.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
CHELIDAMIC ACID
Statistics Data
CHELIDAMIC ACID
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | 1 | 1 |
Statistics Data Visualization
CHELIDAMIC ACID
